FDA approves POLARx cryoablation system from Boston Scientific
Boston Scientific (NYSE: BSX) announced today that it received FDA approval for its POLARx cryoablation system.
Stay updated with breaking news from Wilber Su. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boston Scientific (NYSE: BSX) announced today that it received FDA approval for its POLARx cryoablation system.
First-of-its-kind expandable cryoballoon catheter advances cryoablation therapy, addresses key limitations with traditional systemsÂ
First-of-its-kind expandable cryoballoon catheter advances cryoablation therapy, addresses key limitations with traditional systems MARLBOROUGH, Mass., Aug. 8, 2023 /PRNewswire/ -- Boston Scientific...
The U.S. saw a surge in cardiovascular-related deaths during the first year of the pandemic, and voices from South Dakota's health community hope it spurs more work to prevent these outcomes. New findings from the American Heart Association showed more than 920,000 heart-related deaths in 2020 - the highest total since 2003. ...
February is American Heart Month, and an Arizona expert said it is important to know the signs of a heart attack versus cardiac arrest. Dr. Wilber Su, director of Cardiac Electrophysiology at Banner Health in Phoenix, said both are medical emergencies requiring immediate lifesaving attention, but they are different conditions. ...